Revista Brasileira de Hematologia e Hemoterapia

期刊全称

涉及主题

医学生物内科学遗传学免疫学病理化学生物化学外科心理学

期刊介绍

A Revista Brasileira de Hematologia e Hemoterapia é um periódico científico de propriedade da Associação Brasileira de Hematologia e Hemoterapia, publicada bimestralmente. A abreviatura de seu título é Rev. Bras. Hematol. Hemoter., que deve ser usada em bibliografias, notas de rodapé e em referências e legendas bibliográficas.

Revista Brasileira de Hematologia e Hemoterapia

JCR学科分类

JCI学科分类

期刊相关文献 (21)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience

依维莫司作为难治性或复发性霍奇金淋巴瘤的单一药物：巴西指定患者计划的经验

Erratum to "Frequencies of polymorphisms of Rh, Kell, Kidd, Duffy and Diego systems of Santa Catarina, southern Brazil" [Rev Bras Hematol Hemoter. 2016;38(3):199-205]

“巴西南部圣卡塔琳娜州 Rh、Kell、Kidd、Duffy 和 Diego 系统的多态性频率”的勘误表 [Rev Bras Hematol Hemoter。2016；38(3):199-205]

The F309S mutation increases factor VIII secretion in human cell line

F309S 突变增加人类细胞系中第八因子的分泌

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies

血清游离轻链检测（而非总轻链检测）是评估单克隆丙种球蛋白病的标准治疗方法

Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells

使用 CD138 阳性细胞验证多发性骨髓瘤间期荧光原位杂交 (iFISH)

Frequencies of polymorphisms of the Rh, Kell, Kidd, Duffy and Diego systems of Santa Catarina, Southern Brazil

巴西南部圣卡塔琳娜州 Rh、Kell、Kidd、Duffy 和 Diego 系统的多态性频率

Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais

危险的万能捐献者：米纳斯吉拉斯州贝洛哈里桑塔 Hemocentro 的现实

l-Amino acid oxidase isolated from Calloselasma rhodostoma snake venom induces cytotoxicity and apoptosis in JAK2V617F-positive cell lines

从红口蛇毒中分离的 l-氨基酸氧化酶可在 JAK2V617F 阳性细胞系中诱导细胞毒性和细胞凋亡

Mature B cell neoplasms: retrospective analysis of 93 cases diagnosed between 2011 and 2014 in a University Hospital in southern Brazil

成熟 B 细胞肿瘤：巴西南部一所大学医院 2011 年至 2014 年间诊断的 93 例病例回顾性分析

Comparison between qualitative and real-time polymerase chain reaction to evaluate minimal residual disease in children with acute lymphoblastic leukemia.